3 suspended. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Suspended 3 |
| Phase 1 | 1 | Suspended 1 |
| Phase 3 | 1 | Suspended 1 |
Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors PEN-866, Vincristine, Temozolomide - Sarcoma, Ewing, Rhabdomyosarcoma | Phase 1 / Phase 2 | Suspended | National Cancer Institute (NCI) | 64 | 2024-10-31 | 2026-03-16 |
| A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Bone Scan, Cabozantinib S-malate, Cisplatin - High Grade Osteosarcoma, Localized Osteosarcoma | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 1122 | 2023-03-03 | 2026-10-27 |
| Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma apatinib - Effect of Drug, Toxicity, Drug | Phase 2 | Suspended | Peking University People's Hospital | 44 | 2021-04-01 | 2024-05-14 |
Drug-Related Side Effects and Adverse Reactions (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Ewing (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Bone Tissue (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Sarcoma (2) · Chemically-Induced Disorders (1) · Myosarcoma (1) · Neoplasms, Muscle Tissue (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Doxorubicin (1) · Magnetic Resonance Spectroscopy (1) · Methotrexate (1) · Phantoms, Imaging (1) · Platinum (1) · Surgical Procedures, Operative (1) · Temozolomide (1) · Vincristine (1) · X-Rays (1) · apatinib (1) · cabozantinib (1) · merphos (1)
National Cancer Institute (NCI) (2) · Peking University People's Hospital (1)
United States (2) · Australia (1) · Canada (1) · China (1) · New Zealand (1)
Christine M Heske, M.D. (1) · Michael W Bishop (1) · Wei Guo, M.D. (1)
U10CA180886 (1)